UK markets closed

Nouveau Life Pharmaceuticals, Inc. (NOUV)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00020.0000 (0.00%)
At close: 02:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.33M
Enterprise value 1.33M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)22.72
Enterprise value/revenue N/A
Enterprise value/EBITDA -5.65

Trading information

Stock price history

Beta (5Y monthly) -0.12
52-week change 30.00%
S&P500 52-week change 320.07%
52-week high 30.0003
52-week low 30.0001
50-day moving average 30.0002
200-day moving average 30.0002

Share statistics

Avg vol (3-month) 33.71M
Avg vol (10-day) 3865.46k
Shares outstanding 56.66B
Implied shares outstanding 66.66B
Float 8N/A
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2007
Most-recent quarter (mrq)31 Mar 2012

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-19.83%
Return on equity (ttm)-219.52%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -163.87k
Net income avi to common (ttm)-503.31k
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.1k
Total cash per share (mrq)0
Total debt (mrq)145.37k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.00
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-21.52k
Levered free cash flow (ttm)101.54k